Cancer’s lethality is largely rooted in metastasis—the spread of cancer cells from a primary tumor to distant sites within the body. Central to this process is the capacity of cancer cells to transmigrate through diverse tissue environments, often by bypassing constraints that hamper normal cells. Traditional understanding posited that cellular movement relies predominantly on adhesion to extracellular matrices, enabling cells to pull themselves forward through contraction mechanisms involving the cytoskeleton. However, many invasive cancer cells circumvent this strategy by adopting amoeboid migration, a mode characterized by transient membrane protrusions called blebs that allow cells to squeeze through tight, confining spaces without forming strong adhesions.

At the heart of this pioneering research is the enzyme calcium/calmodulin-dependent protein kinase II (CaMKII). Led by Professor Junichi Ikenouchi, the investigation reveals an unexpected but crucial role of CaMKII in orchestrating the physical forces that drive bleb formation and expansion. While CaMKII has long been recognized for its signaling functions within cells, particularly in neural contexts and calcium-mediated pathways, this study uncovers its mechanical influence—nucleating into large protein supercomplexes that act as an osmotic engine within migrating cancer cells.

The process begins as localized signals elevate internal calcium concentrations within the nascent bleb. In response to this surge, CaMKII undergoes a conformational transition, enabling it to polymerize alongside other proteins into a supercomplex structure. This assembly changes the intracellular osmolarity, creating a steep concentration gradient that actively draws water into the bleb. The hydrated expansion generates a localized increase in hydrostatic pressure, physically pushing the plasma membrane outward and fueling the rapid and forceful protrusions characteristic of amoeboid migration.

This osmotic-based force generation mechanism, termed “CODE” for CaMKII-based Osmotically-driven DEformation, presents a paradigm shift in how cell motility can be driven—not just by cytoskeletal motor proteins or adhesion dynamics but by the spatial reorganization of protein complexes that modulate cellular hydration and pressure. The discovery elucidates a mechanochemical feedback loop wherein biochemical signals modulate physical state changes within the cell, culminating in dynamic morphological transformations required for effective migration.

Prior assumptions attributed membrane bleb growth primarily to passive cytoplasmic pressure diffusing internally, but findings from Ikenouchi’s earlier investigations had already indicated that expanding blebs bear specialized molecular compositions, with markedly enriched calcium ions and signaling constituents distinct from surrounding cytoplasm. This new research now adds a mechanistic layer demonstrating that CaMKII supercomplex formation is not a mere byproduct but the driver of osmotic pressure changes, directly influencing cell shape and motility.

From the clinical standpoint, these insights are extremely significant. Amoeboid migration enables cancer cells to evade therapies targeting adhesion-dependent pathways, such as those inhibiting integrin interactions or extracellular matrix remodeling. By identifying the CODE mechanism as fundamental to this alternative migration style, novel interventions can be devised that specifically disrupt CaMKII supercomplex formation or the associated osmotic engine, potentially halting the invasive behavior of aggressive tumors that rely on amoeboid locomotion.

Beyond oncology, understanding how cells physically generate force by rearranging proteins internally to modulate osmotic pressure could transform regenerative medicine and tissue engineering. Tissue morphogenesis, wound healing, and stem cell migration may all hinge on similar mechanistic principles, where localized protein assembly translates biochemical stimuli into mechanical outputs. Manipulating these processes could allow for the engineering of tissues with enhanced regenerative capacities or improved cellular behaviors for therapeutic applications.

The Kyushu University team employed rigorous experimental methodologies, combining live-cell imaging to observe bleb dynamics, molecular biology assays to quantify CaMKII activity and complex formation, and biophysical measurements to verify osmotic gradients and pressure changes. Their interdisciplinary approach underscores the growing trend in molecular biophysics, where understanding cellular phenomena demands integrative perspectives bridging signaling pathways and mechanical forces.

This research advances the fundamental comprehension of cellular biomechanics by providing compelling evidence that protein-driven osmotic engines are operative within living cells, capable of orchestrating rapid morphological expansions necessary for migration. It challenges the classical view that motor proteins and cytoskeletal contractility are solely responsible for generating protrusive forces and introduces a novel category of intracellular force generators based on fluid dynamics controlled by protein assembly.

Importantly, this work also demonstrates how relatively simple physicochemical principles, such as osmotic pressure governed by solute concentration gradients, are harnessed by cells through sophisticated molecular machinery. CaMKII’s role as a nucleating agent of protein supercomplexes indicates that cellular architecture and function are intricately linked to phase transitions and spatial protein distributions, adding new dimensions to the study of intracellular organization.

The implications for therapeutic development are profound. Targeting the CODE mechanism offers a strategy to incapacitate cancer cell migration without adversely affecting other cellular processes reliant on conventional motility mechanisms. Such specificity could reduce side effects and improve outcomes in treating metastatic cancers. The identification of molecular inhibitors that disrupt CaMKII polymerization or osmotic supercomplex stability stands as an exciting frontier for drug discovery.

In summation, the elucidation of CaMKII-driven osmotic forces powering cancer cell bleb expansion reshapes our understanding of cell migration in oncogenesis. This innovative research not only uncovers a previously invisible layer of mechanobiology but also illuminates new therapeutic landscapes. As cancer continues to defy treatment through cellular plasticity and adaptive mechanisms, decoding such fundamental processes is vital in the quest to outmaneuver this disease at its core.

Subject of Research: Cells

Article Title: CaMKII nucleates an osmotic protein supercomplex to induce cellular bleb expansion

News Publication Date: February 3, 2026

Web References:

• DOI: 10.1038/s44318-026-00703-5
• Kyushu University: https://www.kyushu-u.ac.jp/en/

References:
Fujii, Y., Sakai, Y., Matsuzawa, K., & Ikenouchi, J. (2026). CaMKII nucleates an osmotic protein supercomplex to induce cellular bleb expansion. The EMBO Journal. https://doi.org/10.1038/s44318-026-00703-5

Image Credits: Junichi Ikenouchi / Kyushu University

Keywords

Cancer cell migration, amoeboid migration, bleb expansion, CaMKII, osmotic pressure, protein supercomplex, mechanobiology, metastasis, cellular biomechanics, cytoskeletal dynamics, cellular motility, molecular biophysics

This pioneering study, published in the prestigious journal Proceedings of the National Academy of Sciences (PNAS), challenges the traditional view that cells only interact with their immediate surroundings. Instead, cells appear capable of perceiving mechanical cues from layers of extracellular matrix (ECM) located much deeper than previously assumed. This phenomenon, termed “depth mechano-sensing,” enables cells—notably cancerous ones—to detect and navigate complex tissue landscapes up to 100 microns away.

Mechanical engineer and materials scientist Amit Pathak, who led the research effort, explains that a cell’s mechano-sensing ability depends on its interaction with the fibrous collagen structure that dominates the ECM. By exerting force on this collagen network, cells can physically deform their surroundings, “feeling” the rigidity and composition several layers in depth. This capacity is crucial, as the ECM’s stiffness varies significantly, ranging from soft tissues to rigid bone, providing essential guidance cues for cellular migration.

Previous investigations by Pathak and collaborators demonstrated that single abnormal cells—characterized by a phenomenon called “high front-rear polarity,” common in motile cancer cells—could extend their mechano-sensing reach up to approximately 10 microns. However, the current research reveals a striking amplification of this sensing range when epithelial cells function cohesively as collectives rather than individually. This cellular cooperation dramatically increases the force generated against the collagen fibers, allowing the group to sense up to ten times deeper into the matrix.

What makes this collective behavior particularly intriguing is its implication in cancer progression. Tumor cells often exploit enhanced mechano-sensation to breach primary tumor boundaries, migrating into surrounding tissues and evading immune detection. With the capability to sense and respond to ECM properties far beyond the immediate microenvironment, cancerous epithelial collectives may thus orchestrate more efficient and covert invasion strategies.

Pathak’s team’s computational models shed light on the mechanics underlying this collective sensing. They outline two principal phases: one involving initial cell clustering and another directed migration. The forces generated during cell aggregation enable the group to “probe” the mechanical landscape more effectively than any solitary cell could, setting directional cues that influence not only where but also how cells disperse throughout layered tissue matrices.

The biophysical foundation of this enhanced sensing involves complex interactions between cell-generated traction forces and the nonlinear, fibrous nature of collagen matrices. By remodeling collagen fibers under tension, cells can transmit mechanical signals across distances much larger than their own size. This emergent property of tissue collectives represents a paradigm shift in how scientists view cellular communication and environmental sensing.

Understanding the molecular regulators that enable or restrict this extended sensing ability stands as the next major milestone. Identifying these factors could lead to innovative therapeutic targets. If researchers can inhibit the cell’s ability to perceive the ECM beyond a certain depth, it may be possible to impair the metastatic potential of cancer cells, effectively containing tumors and limiting their invasive spread.

The broader implications of this work transcend oncology. Epithelial cells line almost all body surfaces and are integral to development, wound healing, and immune responses. Their mechano-sensing capacity likely influences a spectrum of physiological and pathological processes, suggesting new avenues for research in tissue engineering and regenerative medicine.

Furthermore, this research contributes to the evolving discourse on how physical forces shape biological outcomes. It emphasizes that cells do not merely respond to chemical signals but also interpret mechanical information transmitted through their surroundings, with collective behavior amplifying these effects in ways previously unimagined.

Pathak and his PhD student Hongsheng Yu, co-authors of this study, have thus paved the way for a deeper understanding of cellular interactions at tissue interfaces. Their findings hint at a form of “cellular clairvoyance,” where groups of cells anticipate environmental obstacles and opportunities through mechanical perception, guiding their movements and fate decisions.

The funding support of the National Institutes of Health and the National Science Foundation underscores the importance and potential impact of this research. As science advances, the intricate dance between cells and their physical environment continues to unravel surprising layers of complexity, challenging existing paradigms and opening new frontiers.

In conclusion, the discovery of emergent depth-mechano-sensing in epithelial collectives marks a transformative step in cell biology. By revealing how cells extend their sensory reach collectively, this work not only deepens our grasp of cancer metastasis but also enriches the broader understanding of tissue mechanics and cellular communication. Future explorations into targeting this capability hold promise for potentially halting cancer’s deadly migration and inspiring novel biomedical innovations.

Subject of Research: Cellular mechanosensing and collective epithelial cell behavior in cancer migration

Article Title: Emergent Depth-Mechano-Sensing of Epithelial Collectives Regulates Cell Clustering and Dispersal on Layered Matrices

News Publication Date: September 11, 2025

Web References:

• Research article: https://www.pnas.org/doi/10.1073/pnas.2423875122
• Researcher profile: https://engineering.washu.edu/faculty/Amit-Pathak.html
• Previous related research: https://doi.org/10.1016/j.celrep.2023.112362
• Source news: https://engineering.washu.edu/news/2025/Working-together-cells-extend-their-senses.html

References:
Hongsheng Y, Pathak A. Emergent depth-mechanosensing of epithelial collectives regulates cell clustering and dispersal on layered matrices. PNAS, Sept. 11, 2025.

Image Credits: Provided by McKelvey School of Engineering, Washington University in St. Louis

Keywords: Cell proliferation, Extracellular spaces, Cellular physiology

Melanoma, although accounting for only a small fraction of skin cancer cases globally, remains disproportionately lethal. It claims nearly 60,000 lives annually and is notorious for its aggressive tendency to metastasize, disseminating cancer cells from the primary tumor site to distant organs. This metastatic progression drastically reduces patient survival rates, with distant metastatic melanoma showing a survival rate of around 35% over five years, compared to an impressive 99% for localized disease. Countering metastasis has, therefore, become a focal point in oncology research, emphasizing the need to unravel cellular mechanisms that govern cancer cell dissemination.

The protein eIF2A, or eukaryotic initiation factor 2A, is traditionally characterized as a mediator of translation initiation, particularly under cellular stress conditions where it helps ribosomes to begin synthesizing proteins. However, the team led by Dr. Fátima Gebauer from the Centre for Genomic Regulation in Barcelona challenges this canonical role by demonstrating that in melanoma cells, eIF2A exerts a previously unappreciated influence on cellular motility, independent of protein synthesis. Their results were recently published in the prestigious journal Science Advances.

Employing a comparative approach using human skin cell lines with differing metastatic competencies, the researchers methodically diminished the functional activity of eIF2A. Their experiments revealed a striking phenomenon: suppressing eIF2A significantly impaired the growth of three-dimensional melanoma tumor spheres and severely hindered cell migration across wound-like scratches in culture dishes. Surpassing initial expectations, the inhibition of eIF2A barely affected overall protein production, indicating that its pro-migratory impact transcends its role in translation initiation.

To delve deeper into this paradox, the research team implemented innovative protein-interaction assays, effectively “fishing out” eIF2A along with its interacting molecular partners. This proteomic mapping unveiled a surprising affinity between eIF2A and multiple components of the centrosome — a critical cellular organelle responsible for organizing microtubules and orchestrating directional cell movement. Notably, when eIF2A levels were compromised, melanoma cells exhibited defects in orienting their centrosomes correctly, thereby losing their navigational cue during migration.

Further mechanistic studies illuminated how eIF2A stabilizes components of the centrosome, ensuring its proper alignment that allows cells to migrate efficiently. The protein’s carboxy-terminal tail appears to serve as an essential scaffolding element, maintaining the integrity of this intracellular compass. Functional truncation of eIF2A’s tail disrupted centrosomal orientation and markedly reduced cellular motility, pinpointing the tail as a promising, druggable target for therapeutic intervention.

Dr. Jennifer Jungfleisch, first author on the study, eloquently described the tail’s role as akin to “cement” that holds together critical elements of melanoma cells’ navigational apparatus. This analogy highlights the protein’s structural rather than enzymatic contribution to metastasis, marking a shift in how eIF2A’s function is conceptualized in the context of cancer cell biology.

Importantly, the study underscores that reliance on eIF2A emerges predominantly after malignant transformation, suggesting that targeting this protein might selectively impair cancer cells while sparing normal, healthy tissues. This tumor-specific dependency could offer a therapeutic window, minimizing collateral damage during treatment — a perennial challenge in oncology drug development.

However, translating these findings from cellular models to in vivo contexts remains an essential next step. The researchers caution that additional studies involving animal models and tissue systems are required to assess how disrupting eIF2A-mediated centrosomal functions impacts tumor spread and overall organismal health.

From a broader perspective, this revelation about eIF2A’s noncanonical role challenges existing paradigms in molecular oncology and cell biology. It exemplifies the complexity of protein functions within cancer cells and the importance of looking beyond traditional roles assigned to molecular players. Such insights could encourage the field to revisit and reevaluate other proteins previously pigeonholed into narrow functional categories.

The discovery of eIF2A’s pivotal role in melanoma cell migration not only shapes the future landscape of anti-metastatic therapies but also exemplifies the innovative spirit driving cancer research forward. As Dr. Gebauer aptly summarized, in an arena where many ostensibly promising targets have fallen short due to redundancy or toxicity, uncovering a protein that becomes indispensable specifically during metastasis is both rare and invaluable.

With metastasis accounting for the vast majority of cancer deaths, strategies that disrupt malignant cell escape and colonization of distant sites hold immense promise. The elucidation of eIF2A’s centrosome-centric function marks an important milestone in this quest, fostering optimism that novel drugs can intercept cancer dissemination at a fundamental biological level.

As the scientific community embraces these findings, continued interdisciplinary collaboration integrating cell biology, oncology, and translational medicine will be crucial. Advancing from molecular characterization to clinical application could eventually herald breakthroughs in melanoma prognosis and treatment, enhancing survival outcomes for thousands afflicted by this aggressive disease worldwide.

Subject of Research: Cells

Article Title: eIF2A regulates cell migration in a translation-independent manner

News Publication Date: 1-Aug-2025

Web References:
10.1126/sciadv.adu5668

Image Credits: Jennifer Jungfleisch/Centro de Regulación Genómica

Keywords: Melanoma, Skin cancer, Cancer